Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

141. Anticoagulation, CHADSVASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study)

Anticoagulation, CHADSVASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study) 26892448 2016 03 29 2016 08 09 2016 03 29 1879-1913 117 8 2016 Apr 15 The American journal of cardiology Am. J. Cardiol. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study). 1294-8 10.1016/j.amjcard.2016.01.024 S0002-9149(16)30146-1 The efficacy of the anticoagulation in preventing (...) thromboembolic complications (TEC) and the usefulness of the CHA2DS2VASc score for assessing stroke risk during cardioversion of acute atrial fibrillation (AF) are unclear. Thus, our objectives were to assess the ability of the CHA2DS2VASc score to predict TEC and to evaluate the efficacy of anticoagulation in the prevention of TEC in Finnish CardioVersion (FinCV) study. The FinCV is a retrospective, multicenter study of 3,143 patients, who underwent 7,660 cardioversions for acute AF. The value

EvidenceUpdates2016

142. Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation | CADTH.ca Find the information you need Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation Published on: March 31, 2016 Project Number: HT0005-TR0005 Product (...) Line: Technology Review Result type: Report Venous thromboembolic events (VTEs) include both deep vein thrombosis (DVT) and pulmonary embolism (PE). VTEs represent an important disease burden in Canada; they are common and likely to increase as the population ages. The standard of care for patients diagnosed with DVT and/or PE has been systemic anticoagulation with heparin (low-molecular-weight heparin [LMWH], administered subcutaneously), followed by oral administration of vitamin K antagonists

CADTH - Plasma Products2016

143. Local Hemostatic Measures Are Enough To Control Bleeding In Implant Patients On Oral Anticoagulation Therapy

Local Hemostatic Measures Are Enough To Control Bleeding In Implant Patients On Oral Anticoagulation Therapy UTCAT3023, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Local Hemostatic Measures Are Enough To Control Bleeding In Implant Patients On Oral Anticoagulation Therapy Clinical Question In a patient on oral anticoagulation therapy, are local hemostatic measures enough to prevent post-procedural bleeding after (...) implant placement? Clinical Bottom Line Local hemostatic measures are proven to be enough. It is not recommended for patients to be taken off of their anticoagulation therapy before a dental implant surgery. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Madrid/2009 2017 adult patients, 19 included studies Systematic Review of Randomized Control Trials, Controlled Clinical Trials, and Prospective Case

UTHSCSA Dental School CAT Library2016

144. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy

D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy 26818781 2016 05 04 2016 05 04 0340-6245 115 5 2016 May 02 Thrombosis and haemostasis Thromb. Haemost. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy. 921-30 10.1160/TH15-07-0529 Coagulation markers may improve monitoring the risk of stroke and (...) bleeding in patients with atrial fibrillation (AF) during anticoagulant treatment. We examined baseline levels of D-dimer and their association with stroke, cardiovascular death and major bleeding in 6,202 AF patients randomised to dabigatran or warfarin in the RE-LY trial. The effects of treatment on serial levels of D-dimer and coagulation factor (F) VIIa in 2,567 patients were also analysed. Baseline D-dimer levels were related to the rate of stroke/systemic embolism (SEE) with 0.64 % in the lowest

EvidenceUpdates2016

145. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study 26819229 2016 06 09 2016 06 09 0340-6245 115 6 2016 Jun 02 Thrombosis and haemostasis Thromb. Haemost. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study. 1101-8 10.1160/TH15-10-0830 The SAMe-TT2R2 score has recently been proposed to predict the quality of vitamin K antagonist (VKA (...) ) anticoagulation control in patients with atrial fibrillation. We aimed at investigating whether the score is effective also in patients with venous thromboembolism (VTE). Patients included in the START-Register because started VKA therapy for a recent VTE episode and with > 3 months follow-up were analyzed. The score was calculated using the baseline patient's characteristics present in the electronic database of the registry, where all INR results were also available and analysed to calculate the time

EvidenceUpdates2016

147. Anticoagulant treatment for subsegmental pulmonary embolism.

Anticoagulant treatment for subsegmental pulmonary embolism. BACKGROUND: Acute pulmonary embolism (PE) is a common cause of death, accounting for 50,000 to 200,000 deaths annually. It is the third most common cause of mortality among the cardiovascular diseases, after coronary artery disease and stroke.The advent of multi-detector computed tomographic pulmonary angiography (CTPA) has allowed better assessment of PE regarding visualisation of the peripheral pulmonary arteries, increasing its (...) by diagnostic imaging performed for other reasons (for example routine CT for cancer staging in oncologic patients).Traditionally, all PEs are anticoagulated in a similar manner independent of the location, number and size of the thrombi. It has been suggested that many patients with SSPE may be treated without benefit, increasing adverse events by possible unnecessary use of anticoagulants.Patients with isolated SSPE or incidental PE may have a more benign clinical presentation compared with those

Cochrane2016

148. Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai

Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai 29063008 2018 11 13 2095-882X 1 4 2015 Dec Chronic diseases and translational medicine Chronic Dis Transl Med Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai. 203-209 10.1016/j.cdtm.2015.11.005 To summarize the use rate, safety, efficacy (...) inpatients with NVAF-associated stroke were studied in our hospital. NVAF was diagnosed by 12-lead electrocardiogram, 24 h Holter and echocardiography. Before introduction of DE (April 2013), use rates of warfarin and antiplatelets were 28.9% (11/38) and 60.5% (23/38) respectively; after that, use rates of warfarin, DE, and antiplatelets were 20.8% (15/72), 12.5% (9/72), and 43.1% (31/72). The DE did not improve use of anticoagulants ( P = 0.639). There were 19 (17.3%) recurrent ischemic stroke events up

Chronic diseases and translational medicine2016 Full Text: Link to full Text with Trip Pro

149. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736004 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):93-4. doi: 10.1056/NEJMc1513255. Bridging Anticoagulation in Patients with Atrial Fibrillation. , , . Comment on [N Engl J Med. 2016] [N Engl J Med. 2015] [N Engl J Med. 2016] [N Engl J Med. 2016] [N Engl J Med. 2016] [N Engl J Med. 2016] PMID: 26736004 DOI: [Indexed for MEDLINE] Free full

NEJM2016

150. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736005 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):90-1. doi: 10.1056/NEJMc1513255#SA1. Bridging Anticoagulation in Patients with Atrial Fibrillation. , . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736005 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons

NEJM2016 Full Text: Link to full Text with Trip Pro

151. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736006 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):91. doi: 10.1056/NEJMc1513255#SA2. Bridging Anticoagulation in Patients with Atrial Fibrillation. , , . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736006 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons

NEJM2016 Full Text: Link to full Text with Trip Pro

152. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736007 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):91-2. doi: 10.1056/NEJMc1513255#SA3. Bridging Anticoagulation in Patients with Atrial Fibrillation. , , . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736007 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed

NEJM2016 Full Text: Link to full Text with Trip Pro

153. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736008 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):92. doi: 10.1056/NEJMc1513255#SA4. Bridging Anticoagulation in Patients with Atrial Fibrillation. , , . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736008 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons

NEJM2016 Full Text: Link to full Text with Trip Pro

154. Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation. Bridging Anticoagulation in Patients with Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26736009 Format MeSH and Other Data (...) E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2016 Jan 7;374(1):92-3. doi: 10.1056/NEJMc1513255#SA5. Bridging Anticoagulation in Patients with Atrial Fibrillation. . Comment in [N Engl J Med. 2016] Comment on [N Engl J Med. 2015] PMID: 26736009 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical PubMed Commons 0

NEJM2016 Full Text: Link to full Text with Trip Pro

155. Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature 27747798 2018 11 13 2199-1154 3 1 2016 Mar Drugs - real world outcomes Drugs Real World Outcomes Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature. 1-6 Hair loss is associated with the anticoagulants heparin and warfarin. With the recent availability of direct oral anticoagulants (DOACs) it is of clinical interest to know (...) if they are implicated with hair loss and/or whether they could be successfully prescribed for patients who suffer from coumarin- or heparin-related alopecia. Initially reports of heparin- and coumarin-associated alopecia available through PubMed and Medline were explored in order to establish the cause of this side effect. Currently there is a lack of unanimity on why anticoagulants cause alopecia. However, timing and presentation strongly suggest that telogen effluvium is part of the process. The observation

Drugs - real world outcomes2016 Full Text: Link to full Text with Trip Pro

156. New/Novel Oral Anticoagulants (NOACs): Management of Bleeding

New/Novel Oral Anticoagulants (NOACs): Management of Bleeding © 2016 Thrombosis Canada Page 1 of 1 NOVEL ORAL ANTICOAGULANTS (NOACS): MANAGEMENT OF BLEEDING OBJECTIVE: To assist clinicians in the management of bleeding in patients receiving direct oral anticoagulants (NOACs). BACKGROUND: Two oral Factor Xa inhibitors (apixaban and rivaroxaban) and an oral thrombin inhibitor (dabigatran) are approved for clinical use in Canada based on findings from large randomized trials. Like all other (...) anticoagulants, bleeding is the major complication of therapy. Specific antidotes for these drugs are expected to be available soon. Studies of successful reversal strategies using non-specific products in patients with bleeding have not been reported. Appropriate management in all cases of bleeding requires a systematic approach to assessing the competing risks and consequences of bleeding and thrombosis. MANAGEMENT OF BLEEDING EPISODES Minor Bleeding e.g. anterior epistaxis, hemorrhoid bleeding

Thrombosis Interest Group of Canada2016

157. Anticoagulation therapy guidelines for open heart mechanical valve replacement patients

Anticoagulation therapy guidelines for open heart mechanical valve replacement patients Anticoagulation therapy guidelines for open heart mechanical valve replacement patients Anticoagulation therapy guidelines for open heart mechanical valve replacement patients Mitchell, MD, Cardona, LA, Herrmann, HC, Szeto, WY, Mull, N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Mitchell, MD, Cardona, LA, Herrmann, HC, Szeto, WY, Mull, N. Anticoagulation therapy guidelines for open heart mechanical valve replacement patients. Philadelphia: Center for Evidence-based Practice (CEP). 2016 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Cardiac Surgical Procedures; Humans; Thrombolytic Therapy Language Published English Country of organisation United States English summary An English language summary is available. Address

Health Technology Assessment (HTA) Database.2016

158. Patient self-monitoring oral anticoagulation therapy

Patient self-monitoring oral anticoagulation therapy evidence note Update of evidence note 50 Number 57 November 2015 Is patient self-monitoring (including self-testing and self- management) of oral anticoagulation therapy safe, efficacious and cost-effective? What is an evidence note Evidence notes are rapid reviews of published secondary clinical and cost-effectiveness evidence on health technologies under consideration by decision-makers within NHSScotland. They are intended to provide (...) strategy when compared with usual care. However, further analyses demonstrated that, although self-management was cost- effective, self-testing was not. It is worth noting that cost effectiveness of self-management is based on the assumption that it leads to a reduction in thromboembolic events. ? The findings support the view that the cost effectiveness of self-monitoring is strongly contingent on the patient being able to manage their own oral anticoagulation therapy. By doing so, this helps

Evidence Notes from Healthcare Improvement Scotland2016

159. Cohort study: Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism

Cohort study: Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all-cause mortality and thromboembolism | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Restarting oral anticoagulation among patients with atrial fibrillation with gastrointestinal bleeding was associated with lower risk of all

Evidence-Based Medicine (Requires free registration)2016

160. Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism?

Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism? DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Annals of Emergency Medicine Systematic Review Snapshots2016